AstraZeneca's Partnership With Amgen Ends Abruptly

Shares of both AstraZeneca and Amgen declined after announcing the end of a partnership for psoriasis drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.